Đang chuẩn bị liên kết để tải về tài liệu:
Enhanced-pharmacokinetic-performance-of-dapoxetine-hydrochlorid_2020_Journal
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Instantly dissolving buccal films have gained attention owing to their easy administration and capability to surmount the hepatic first pass effect of drugs. Dapoxetine hydrochloride (DPX) has a low oral bioavailability due to significant hepatic first pass metabolism. In addition, DPX is a weakly basic drug with a pH dependent solubility that could limit its dissolution in the body neutral fluids. In order to surpass these challenges, this work aimed at enhancing DPX bioavailability via the formulation of instantly dissolving buccal films comprising a pH modifier and a hydrophilic cyclodextrin. | Enhanced-pharmacokinetic-performance-of-dapoxetine-hydrochlorid_2020_Journal